Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Amyloid beta concentrations in older people with Down syndrome and dementia.

Neuroscience letters - 20 Feb 2009

Jones Emma L, Hanney Marisa, Francis Paul T, Ballard Clive G

Abstract excerpt

People with Down syndrome develop Alzheimer's disease with an early age of onset. Plasma amyloid beta (Abeta) levels were measured in individuals with Down syndrome who were over the age of 40. No associations between age and Abeta1-40 and Abeta1-42 concentrations were found and nor were Abeta1-40 and Abeta1-42 levels found to vary between those with Alzheimer's-type dementia and those without dementia. The APOE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Comorbidity

Share to Down Syndrome

Share to Peptide Fragments

Share to Sex Factors

Source

Identifiers

PMID: 19111900
DOI: 10.1016/j.neulet.2008.12.030

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Amyloid beta concentrations in older people with Down syndrome and dementia.PMID 19111900Read ↗

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.Semantic proximity Read ↗

Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Semantic proximity Read ↗

Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome.Semantic proximity Read ↗

Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changesSemantic proximity Read ↗

Genetic and host factors for dementia in Down's syndrome.Semantic proximity Read ↗

Beta-amyloid, oxidative stress and down syndrome.Semantic proximity Read ↗

Apo E genotypes and risk of dementia in Down syndrome.Semantic proximity Read ↗

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.Semantic proximity Read ↗

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.Semantic proximity Read ↗

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s diseaseSemantic proximity Read ↗

ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis.Semantic proximity Read ↗

Increased risk of Alzheimer's disease in mothers of adults with Down's syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.